跳至主要内容
临床试验/NCT00583258
NCT00583258撤回不适用

A Randomized, Double-Blinded Placebo-Controlled Trial of Alfuzosin (Xatral)in the Management of Distal Ureteral Calculi

Unity Health Toronto1 个研究点 分布在 1 个国家开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
The primary outcome will be Cox proportional hazards survival analysis of stone passage over time

研究概览

简要总结

Patients who present for the first time to Emergency Room with renal colic due to a distal ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study is to assess if patients treated with Xatral will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • first presentation to ER with renal colic secondary to a distal ureteral stone diagnosed on spiral CT scan
  • stone radiopaque on KUB, distal to the sacro-iliac joint
  • patient suitable for discharge from ER
  • patient willing to return for follow-up on a weekly basis for maximum 4 visits

排除标准

  • more than one ureteral calculi
  • radiolucent stones or cystine stones
  • prior ipsilateral calculus or ureteral surgery
  • congenital anomalies of the ureter
  • patients presents with an absolute indication for intervention
  • allergy or contraindication to NSAIDs (history of orthostatic hypotension, current systolic BP <90 mmHg)
  • patient currently taking an alpha-blocker
  • hepatic insufficiency
  • pregnancy

研究组 & 干预措施

A

Experimental

干预措施: Alfuzosin (Xatral) (Drug)

B

Placebo Comparator

干预措施: Placebo Alfuzosin (Drug)

结局指标

主要结局

The primary outcome will be Cox proportional hazards survival analysis of stone passage over time

时间窗: 4 weeks

次要结局

  • Secondary outcomes will be stone passage rates, pain scores, intervention rates, hospitalization rates and complication rates(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验